Myriad Genetics (MYGN)

Add to Watchlists
Create an Alert
35.35 -0.41  -1.15% NASDAQ Mar 30, 5:00PM BATS Real time Currency in USD
View Full Chart
MYGN Price Chart
View All Events

MYGN Events

Date Type Description
02/03/2015 16:30 EST Misc Myriad Genetics Inc Second Quarter Earnings Conference Call in 2015
02/03/2015 Earnings Myriad Genetics Inc Second Quarter Earnings in 2015 Release
11/04/2014 16:30 EDT Misc Q1 2015 Myriad Genetics Inc Earnings Conference Call
11/04/2014 Earnings Q1 2015 Myriad Genetics Inc Earnings Results
08/12/2014 16:30 EDT Misc Q4 2014 Myriad Genetics Inc Earnings Conference Call
08/12/2014 Earnings Q4 2014 Myriad Genetics Inc Earnings Results
05/06/2014 16:30 EDT Misc Q3 2014 Myriad Genetics Inc Earnings Conference Call
05/06/2014 Earnings Q3 2014 Myriad Genetics Inc Earnings Results
View All Performance Charts

MYGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Myriad Genetics is up 5.93% over the last year vs S&P 500 Total Return up 15.16%, Affymetrix up 86.50%, and Quest Diagnostics up 37.09%.

Get Quote for

PDF Report for MYGN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download MYGN Pro Report PDF
Advertisement

Portfolio Strategies Featuring MYGN

Did Myriad Genetics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

MYGN Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Company Website: http://www.myriad.com
  • IR Website: http://investor.myriad.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: Utah
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: March 31, 2015
  • Est. Current Fiscal Year End: June 30, 2015
  • Last Fiscal Quarter End: December 31, 2014
  • Last Fiscal Year End: June 30, 2014
  • Next Earnings Release: N/A
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.

MYGN Excel Add-In Codes

  • Name: =YCI("MYGN","name")
  • Description: =YCI("MYGN","description")
  • Sector: =YCI("MYGN","sector")
  • Industry: =YCI("MYGN","industry")
  • Est. Current Fiscal Year End: =YCI("MYGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.